| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-14 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-12 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-12 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |